1. Home
  2. AM vs RGEN Comparison

AM vs RGEN Comparison

Compare AM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Midstream Corporation

AM

Antero Midstream Corporation

HOLD

Current Price

$22.79

Market Cap

10.2B

Sector

Utilities

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$115.18

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AM
RGEN
Founded
2013
1981
Country
United States
United States
Employees
N/A
2000
Industry
Natural Gas Distribution
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
6.6B
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
AM
RGEN
Price
$22.79
$115.18
Analyst Decision
Hold
Buy
Analyst Count
4
11
Target Price
$22.50
$172.91
AVG Volume (30 Days)
2.3M
873.1K
Earning Date
04-29-2026
04-28-2026
Dividend Yield
3.98%
N/A
EPS Growth
3.61
286.96
EPS
0.86
0.86
Revenue
$1,188,426,000.00
$141,236,000.00
Revenue This Year
$4.92
$14.30
Revenue Next Year
$6.74
$14.52
P/E Ratio
$26.27
$136.09
Revenue Growth
7.43
35.10
52 Week Low
$15.08
$105.06
52 Week High
$23.84
$175.77

Technical Indicators

Market Signals
Indicator
AM
RGEN
Relative Strength Index (RSI) 53.98 41.20
Support Level $22.45 $112.05
Resistance Level $23.84 $130.56
Average True Range (ATR) 0.54 4.53
MACD -0.16 1.25
Stochastic Oscillator 36.45 47.57

Price Performance

Historical Comparison
AM
RGEN

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: